What a 7% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
Testing Dispatch
Independent analysis puts a BCH mazdutide lot at 98.6%, against 96.0% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
A peptide content determination commissioned by the Journal on a 30 mg mazdutide vial from BCH has returned 96% of the labelled mass. Chromatographic purity on the same vial was above 98.6%. The two numbers measure different things and only one of them was on the certificate.
The Journal purchased 2300 vials from the same lot and had 18 of them analysed separately, in order to distinguish vial-to-vial variation from method variation. Vial-to-vial agreement was within 0.4 percentage points. Method-to-method disagreement was an order of magnitude larger.
The Journal purchased 2300 vials from the same lot and had 18 of them analysed separately, in order to distinguish vial-to-vial variation from method variation. Vial-to-vial agreement was within 0.4 percentage points. Method-to-method disagreement was an order of magnitude larger.
Purity became this trade’s single figure of merit because it is the cheapest measurement to obtain and the easiest to compare. Peptide content, which determines how much drug is actually in a vial, costs several times as much and is not offered as a standard release test by any of the twenty companies in the Journal’s dossier programme. Sterility and endotoxin are separate disciplines again, and are neither tested nor claimed.
Yusuf Kandemir, freight and customs broker, Istanbul, was more cautious. "One lot tells you about one lot. I would not draw a conclusion about a company from a single determination, and I would not let a company draw one either."
BCH’s dossier has been updated with this determination and with the date of the request for comment. The dossier’s "what we could not verify" box records the questions still outstanding.
Related coverage
Leucine, isoleucine, and a difference no balance can measure
Stereochemical inversion changes the molecule, changes its biology, and changes its mass by exactly nothing.
KP declines, for the 15th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Tianjin semaglutide lot lands 1.1 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Independent analysis puts a MKM survodutide lot at 96.5%, against 95.5% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
The retest date and the expiry date are not the same document
A retest date says that material should be re-examined before use. An expiry date says it should not be used. The trade uses the second word for the first concept.